• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA Back to Work; Gottlieb Announces New Clinical Trial Plan

FDA Back to Work; Gottlieb Announces New Clinical Trial Plan

January 28, 2019

On the first day back to work after the record-breaking government shutdown, FDA Commissioner Scott Gottlieb announced new plans to explore the use of digital technologies that bring trials to patients and increase access to real-world evidence.

He said Monday that the agency has established a formal working group on decentralized trials and is now developing a guidance document.

Improving trial access, Gottlieb said, can generate a more diverse patient population and help investigators collect data that better reflects the real world.

“By working collaboratively with the clinical trial community and patient groups, we can develop scientific and technical standards for incorporating new technologies into clinical trials to make them more agile and accessible to patients and regulators,” Gottlieb said.

Also on Monday, CDER Director Janet Woodcock briefed newly returned staff on plans and priorities for catching up with business that was postponed over the past six weeks.

“Every firm with an issue pending before us will be asking for a timeframe, and the trade press and others will be asking for estimates,” Woodcock said.

“We always try to be helpful to outside stakeholders, but in this case, we need to make collective decisions, so please do not give out estimates. Over the next few days, as we sort through what is pending, we will make plans and disseminate them, so we will all be working from the same playbook, she added.”

How long that playbook will be active is uncertain, however. The stopgap funding bill signed on Friday will keep the government open for only three weeks while Congress and the White House work to resolve their differences on immigration reform. Temporary funding provided by the bill will run out on Feb. 15.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing